Early reaction to CEO Elizabeth Holmes' presentation at the American Association for Clinical Chemistry (AACC) in Philadelphia this week has trended negative, as shown below. (Links after the break.)
Youtube Archive (90 minutes): AACC, Youtube, here.
August 1, 2016.
Holmes Speaks at AACC Conference.
Forbes, Matthew Herper, Live Blog (archive) here.
WSJ, John Carreyou, here.
CNBC, article and video story, here.
Wired, Nick Stockton, here.
One of the most detailed reports is at Dark Daily, here.
Youtube Archive (90 minutes): AACC, Youtube, here.
August 1, 2016
"Theranos' Highly-Anticipated Defense of Its Tech Is Called a Bait-and-Switch."
Fortune. By Sy Mukherjee. Here.
"How Theranos Created and Destroyed Investors' Trust."
Fortune. By Kent Grayson. Here.
"Theranos Offers First Glimpse of Technologies, Assay Data to Critical Lab Community."
Genomeweb [subscription]. By Turna Ray. Here.
August 2, 2016
"The Founder of Theranos Tries to Change the Subject."
The New Yorker. By Sheelah Kolhatkar. Here.
"How Theranos' Reboot Could Backfire."
Washington Post. By Carolyn Y. Johnson. Here.
"Theranos Plunges Ahead Into a Murky Future."
Statnews. By Damian Garde. Here.
August 3, 2016
"Theranos CEO Quietly Steps Down from Presidential Entrepreneurship Program."
California Healthline. [Name, photo removed from website.] Here. At Breitbart, here.
____
For John P.A. Ioannidis' second Theranos article, in JAMA on July 26, 2016, here. Photo set below, click to enlarge.
